0001140361-24-045485.txt : 20241107 0001140361-24-045485.hdr.sgml : 20241107 20241107060836 ACCESSION NUMBER: 0001140361-24-045485 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 EFFECTIVENESS DATE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Opus Genetics, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528843 FILM NUMBER: 241432910 BUSINESS ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 FORMER COMPANY: FORMER CONFORMED NAME: Ocuphire Pharma, Inc. DATE OF NAME CHANGE: 20201109 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 D 1 primary_doc.xml X0708 D LIVE 0001228627 Opus Genetics, Inc. 37000 Grand River Avenue Suite 120 Farmington Hills MI MICHIGAN 48335 1 (248) 957-9024 DELAWARE Rexahn Pharmaceuticals, Inc. Ocuphire Pharma, Inc. REXAHN PHARMACEUTICALS, INC. CORPORATE ROAD SHOW DOT COM INC Corporation true Dr. George Magrath c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Executive Officer Dr. Benjamin Yerxa c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Executive Officer Nirav Jhaveri c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Ash Jayagopal c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Cam Gallagher c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Sean Ainsworth c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Susan Benton c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director James Manuso c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Richard Rodgers c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Dr. Jean Bennett c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Dr. Adrienne Graves c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Bernhard Hoffmann c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Amy Rabourn c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Joseph Schachle c/o Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Biotechnology Decline to Disclose 06b false 2024-10-22 false true true Issued in connection with merger transaction between Opus Genetics, Inc. (formerly known as Ocuphire Pharma, Inc.) and Opus Genetics Inc., as further disclosed in a current report on Form 8-K filed on October 22, 2024. 0 25778641 25778641 0 false 11 0 0 0 false Opus Genetics, Inc. /s/ Dr. George Magrath Dr. George Magrath Chief Executive Officer & Director 2024-11-06